Impact of provider mailings on medication adherence by Medicare Part D members

The Medicare 5-Star Rating System measures and provides incentive for improving Medicare Part D plans through a quality-based payment program. Adherence to medications for chronic conditions is key to the Star ratings. Our objective was to assess the impact of direct-to-provider letters on improving...

Full description

Saved in:
Bibliographic Details
Published inHealthcare : the journal of delivery science and innovation Vol. 4; no. 3; pp. 207 - 216
Main Authors Borah, Bijan J., Qiu, Yang, Shah, Nilay D., Gleason, Patrick P.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The Medicare 5-Star Rating System measures and provides incentive for improving Medicare Part D plans through a quality-based payment program. Adherence to medications for chronic conditions is key to the Star ratings. Our objective was to assess the impact of direct-to-provider letters on improving medication adherence. Members of a large US pharmacy benefits manager (PBM) who did not adhere to prescription of oral diabetes (antidiabetics), cholesterol-reducing (statins), or hypertension (renin angiotensin system [RAS] antagonists) drug therapy were identified from the prescriptions claims data of>600,000 continuously enrolled Medicare members. Nonadherence was defined by the Star ratings definition of proportion of days covered (PDC)<80%. The PBM sent letters to prescribing physicians of nonadherent members, requesting that they discuss adherence barriers and potential solutions with their patients. A historical control cohort was constructed from the PBM satisfying the same eligibility criteria as the intervention cohort. Both binary (≥80%) and continuous PDC measures were assessed as outcomes through multivariate logistic regression and difference-in-difference models, respectively. Final sample sizes were 21,044; 106,829; and 73,560 patients for antidiabetic, statin, and RAS antagonist use, respectively, with approximately equal number of intervention and control subjects in each drug class. Physician mailing was associated with 11%, 16%, and 7% higher odds of being adherent by members in antidiabetic, statin, and RAS antagonist cohorts, respectively (all P<.001). Within limitations of historical controls, physician mailing was associated with improved medication adherence. Physician mailing can be an impactful tool for improving medication adherence. II
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:2213-0764
2213-0772
DOI:10.1016/j.hjdsi.2016.02.004